Assessing the Impact of the <scp>COVID</scp> ‐19 Pandemic on Relative Incidence Rates in United States Claims Data
Claims-based time trend or comparative incidence studies could be biased due to the pandemic depending on the underlying population and outcome of interest.
Authors
- Sarah‐Jo Sinnott (ORCID: https://orcid.org/0000-0001-7586-686X)
- Julie Barberio (ORCID: https://orcid.org/0000-0002-8678-7339)
- V Harikrishnan
- Xinyu Li (ORCID: https://orcid.org/0000-0001-7175-7332)
- Kexin Zhu (ORCID: https://orcid.org/0000-0001-7173-6881)
Institutions
- Morristown Medical Center (US)
- Sanofi (United States) (US)
- C3I (United States) (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-10-26
- DOI
- https://doi.org/10.1002/pds.70246
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi